Exoskeleton Variability Optimization

Description

The investigators will evaluate a potentially faster and more clinically feasible method to optimize exoskeletons in pilot tests in healthy in preparation for patients with peripheral artery disease.

Conditions

Peripheral Arterial Disease

Study Overview

Study Details

Study overview

The investigators will evaluate a potentially faster and more clinically feasible method to optimize exoskeletons in pilot tests in healthy in preparation for patients with peripheral artery disease.

Exoskeleton Variability Optimization for Reducing Gait Variability for Patients With Peripheral Artery Disease

Exoskeleton Variability Optimization

Condition
Peripheral Arterial Disease
Intervention / Treatment

-

Contacts and Locations

Omaha

University of Nebraska Omaha, Omaha, Nebraska, United States, 68182

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Ability to provide written consent
  • * Chronic claudication history
  • * Ankle-brachial index \< 0.90 at rest
  • * Stable blood pressure, lipides, and diabetes for \> 6 weeks
  • * Ability to walk on a treadmill for multiple five-minute spans.
  • * Ability to fit in exoskeleton: waist circumference 78 to 92 centimeters, thigh circumference 48 to 60 centimeters, minimal thigh length 28 centimeters.
  • * Rest pain or tissue loss due to peripheral artery disease (Fontaine stage III and IV).
  • * Foot ulceration.
  • * Acute lower extremity event secondary to thromboembolic disease or acute trauma
  • * Walking capacity limited by diseases which are unrelated to peripheral artery disease such as:
  • * Acute injury or pain in their lower extremity or current illness.
  • * Inability to follow visual cues due to blindness.
  • * Inability to follow auditory cues due to deafness.
  • * Women who are currently pregnant are excluded for safety reasons.

Ages Eligible for Study

19 Years to 85 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Nebraska,

Philippe Malcolm, PRINCIPAL_INVESTIGATOR, University of Nebraska

Study Record Dates

2025-08